Pacific Biosciences is partnering with tychobio ai on a large-scale full-length RNA sequencing effort to train AI models for rare disease drug discovery. PacBio said it will use HiFi and Kinnex on more than 10,000 samples, extending its biopharma push.
published
Pacific Biosciences is partnering with tychobio ai on a large-scale full-length RNA sequencing effort to train AI models for rare disease drug discovery. PacBio said it will use HiFi and Kinnex on more than 10,000 samples, extending its biopharma push.
Latest documented BWB result
$NVDA market result
Exit $NVDA with $3 profit per share
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.